NBIS trades 18.4% above Wall Street's consensus target of $196.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes NBIS achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 8 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 28, 2026, Nebius Group N.V. (NBIS) has a Wall Street consensus price target of $196.00, based on estimates from 8 covering analysts. With the stock currently trading at $240.30, this represents a potential downside of -18.4%. The company has a market capitalization of $57.67B.
Analyst price targets range from a low of $129.00 to a high of $255.00, representing a 64% spread in expectations. The median target of $199.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 7 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, NBIS trades at a trailing P/E of 2184.5x. Analysts expect EPS to grow -178.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $39.45, with bear and bull scenarios of $24.85 and $51.98 respectively. Model confidence stands at 44/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
LGNDLigand Pharmaceuticals Incorporated | $6.1B | $303.59 | $265.33 | -12.6% | Buy | 33.5x | 17 |
GPUSHyperscale Data, Inc. | $67M | $0.18 | — | — | — | — | — |
ANETArista Networks, Inc. | $198.4B | $157.60 | $185.45 | +17.7% | Buy | 43.4x | 52 |
VRTVertiv Holdings Co | $116.7B | $303.95 | $375.08 | +23.4% | Buy | 46.9x | 19 |
AMZNAmazon.com, Inc. | $2.5T | $232.69 | $307.77 | +32.3% | Buy | 26.5x | 94 |
MSFTMicrosoft Corporation | $2.8T | $372.97 | $551.33 | +47.8% | Buy | 22.2x | 82 |
GOOGLAlphabet Inc. | $4.1T | $337.39 | $411.80 | +22.1% | Buy | 23.7x | 83 |
ORCLOracle Corporation | $427.6B | $148.68 | $253.50 | +70.5% | Buy | 18.5x | 86 |
IBMInternational Business Machines Corporation | $254.8B | $271.63 | $314.83 | +15.9% | Buy | 21.8x | 50 |
DDOGDatadog, Inc. | $85.3B | $239.77 | $231.21 | -3.6% | Buy | 98.8x | 48 |
Quick answers to the most common questions about buying NBIS stock.
NBIS's consensus price target is $196, -18.4% below the current price of $240.3. The 8 analysts tracking NBIS see downside risk at present valuations.
NBIS has a consensus rating of "Buy" based on 8 Wall Street analysts. The rating breakdown is predominantly bullish, with 7 Buy/Strong Buy ratings. The consensus 12-month price target of $196 implies -18.4% downside from current levels.
NBIS's current price is $240.3 with a consensus target of $196 (-18.4% implied move). Analyst estimates suggest the stock is overvalued at current levels.
The most bullish Wall Street analyst has a price target of $255 for NBIS, while the most conservative target is $129. The consensus of $196 represents the median expectation. Our quantitative valuation model projects a bull case target of $52 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
NBIS is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 7 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month NBIS stock forecast based on 8 Wall Street analysts shows a consensus price target of $196, with estimates ranging from $129 (bear case) to $255 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $39, with bear/bull scenarios of $25/$52.
Our quantitative valuation model calculates NBIS's fair value at $39 (base case), with a bear case of $25 and bull case of $52. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 44/100.
Analysts are cautious on NBIS, with 0 Sell ratings and a price target of $196 (-18.4% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
NBIS analyst price targets range from $129 to $255, a 64% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $196 consensus represents the middle ground. Our model's $25-$52 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.